Earlier this month, Ardelyx presented new data from the first real-world study of XPHOZAH at the American Society of Nephrology's Kidney Week in Houston, highlighting its use for adults with chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback